img

Global mRNA Platform Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global mRNA Platform Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global mRNA Platform market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Infectious Disease Vaccines accounting for % of the mRNA Platform global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Infectious Disease segment is altered to an % CAGR throughout this forecast period.
The global key companies of mRNA Platform include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States mRNA Platform market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe mRNA Platform landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global mRNA Platform market. The analysts authoring the report have closely studied key strategies adopted by top players of the global mRNA Platform market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global mRNA Platform market. Readers of the report can become informed about current and future trends of the global mRNA Platform market and how they will impact market growth during the forecast period.



By Company


Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines

Segment by Application


Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of mRNA Platform in global and regional level.
Chapter 3Detailed analysis of mRNA Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Platform revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Platform Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Platform Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global mRNA Platform Market Size (2018-2034)
2.2 mRNA Platform Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global mRNA Platform Market Size by Region (2018-2024)
2.4 Global mRNA Platform Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 mRNA Platform Countries Ranking by Market Size
3 mRNA Platform Competitive by Company
3.1 Global mRNA Platform Revenue by Players
3.1.1 Global mRNA Platform Revenue by Players (2018-2024)
3.1.2 Global mRNA Platform Market Share by Players (2018-2024)
3.2 Global mRNA Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by mRNA Platform Revenue
3.4 Global mRNA Platform Market Concentration Ratio
3.4.1 Global mRNA Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Platform Revenue in 2022
3.5 Global Key Players of mRNA Platform Head office and Area Served
3.6 Global Key Players of mRNA Platform, Product and Application
3.7 Global Key Players of mRNA Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global mRNA Platform Breakdown Data by Type
4.1 Global mRNA Platform Historic Revenue by Type (2018-2024)
4.2 Global mRNA Platform Forecasted Revenue by Type (2024-2034)
5 Global mRNA Platform Breakdown Data by Application
5.1 Global mRNA Platform Historic Market Size by Application (2018-2024)
5.2 Global mRNA Platform Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America mRNA Platform Revenue by Company (2021-2024)
6.2 North America mRNA Platform Revenue by Type (2018-2034)
6.3 North America mRNA Platform Revenue by Application (2018-2034)
6.4 North America mRNA Platform Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe mRNA Platform Revenue by Company (2021-2024)
7.2 Europe mRNA Platform Revenue by Type (2018-2034)
7.3 Europe mRNA Platform Revenue by Application (2018-2034)
7.4 Europe mRNA Platform Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific mRNA Platform Revenue by Company (2021-2024)
8.2 Asia Pacific mRNA Platform Revenue by Type (2018-2034)
8.3 Asia Pacific mRNA Platform Revenue by Application (2018-2034)
8.4 Asia Pacific mRNA Platform Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America mRNA Platform Revenue by Company (2021-2024)
9.2 Latin America mRNA Platform Revenue by Type (2018-2034)
9.3 Latin America mRNA Platform Revenue by Application (2018-2034)
9.4 Latin America mRNA Platform Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa mRNA Platform Revenue by Company (2021-2024)
10.2 Middle East and Africa mRNA Platform Revenue by Type (2018-2034)
10.3 Middle East and Africa mRNA Platform Revenue by Application (2018-2034)
10.4 Middle East and Africa mRNA Platform Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Arcturus Therapeutic
11.1.1 Arcturus Therapeutic Company Details
11.1.2 Arcturus Therapeutic Business Overview
11.1.3 Arcturus Therapeutic mRNA Platform Products and Services
11.1.4 Arcturus Therapeutic mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.1.5 Arcturus Therapeutic mRNA Platform SWOT Analysis
11.1.6 Arcturus Therapeutic Recent Development
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Details
11.2.2 Argos Therapeutics Business Overview
11.2.3 Argos Therapeutics mRNA Platform Products and Services
11.2.4 Argos Therapeutics mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.2.5 Argos Therapeutics mRNA Platform SWOT Analysis
11.2.6 Argos Therapeutics Recent Development
11.3 BioNTec
11.3.1 BioNTec Company Details
11.3.2 BioNTec Business Overview
11.3.3 BioNTec mRNA Platform Products and Services
11.3.4 BioNTec mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.3.5 BioNTec mRNA Platform SWOT Analysis
11.3.6 BioNTec Recent Development
11.4 CureVac
11.4.1 CureVac Company Details
11.4.2 CureVac Business Overview
11.4.3 CureVac mRNA Platform Products and Services
11.4.4 CureVac mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.4.5 CureVac mRNA Platform SWOT Analysis
11.4.6 CureVac Recent Development
11.5 Etherna
11.5.1 Etherna Company Details
11.5.2 Etherna Business Overview
11.5.3 Etherna mRNA Platform Products and Services
11.5.4 Etherna mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.5.5 Etherna mRNA Platform SWOT Analysis
11.5.6 Etherna Recent Development
11.6 Ethris
11.6.1 Ethris Company Details
11.6.2 Ethris Business Overview
11.6.3 Ethris mRNA Platform Products and Services
11.6.4 Ethris mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.6.5 Ethris mRNA Platform SWOT Analysis
11.6.6 Ethris Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline mRNA Platform Products and Services
11.7.4 GlaxoSmithKline mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.7.5 GlaxoSmithKline mRNA Platform SWOT Analysis
11.7.6 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer mRNA Platform Products and Services
11.8.4 Pfizer mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.8.5 Pfizer mRNA Platform SWOT Analysis
11.8.6 Pfizer Recent Development
11.9 Translate Bio
11.9.1 Translate Bio Company Details
11.9.2 Translate Bio Business Overview
11.9.3 Translate Bio mRNA Platform Products and Services
11.9.4 Translate Bio mRNA Platform Revenue in mRNA Platform Business (2018-2024)
11.9.5 Translate Bio mRNA Platform SWOT Analysis
11.9.6 Translate Bio Recent Development
12 mRNA Platform Market Dynamics
12.1 mRNA Platform Industry Trends
12.2 mRNA Platform Market Drivers
12.3 mRNA Platform Market Challenges
12.4 mRNA Platform Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global mRNA Platform Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Infectious Disease Vaccines
Table 3. Key Players of Cancer Vaccines
Table 4. Global mRNA Platform Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global mRNA Platform Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 6. Global mRNA Platform Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global mRNA Platform Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 8. Global mRNA Platform Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 9. Global mRNA Platform Revenue by Players (2018-2024) & (US$ Million)
Table 10. Global mRNA Platform Market Share by Players (2018-2024)
Table 11. Global Top mRNA Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Platform as of 2022)
Table 12. Ranking of Global Top mRNA Platform Companies by Revenue (US$ Million) in 2022
Table 13. Global 5 Largest Players Market Share by mRNA Platform Revenue (CR5 and HHI) & (2018-2024)
Table 14. Global Key Players of mRNA Platform, Headquarters and Area Served
Table 15. Global Key Players of mRNA Platform, Product and Application
Table 16. Global Key Players of mRNA Platform, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global mRNA Platform Market Size by Type (2018-2024) & (US$ Million)
Table 19. Global mRNA Platform Revenue Market Share by Type (2018-2024)
Table 20. Global mRNA Platform Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 21. Global mRNA Platform Revenue Market Share by Type (2024-2034)
Table 22. Global mRNA Platform Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global mRNA Platform Revenue Market Share by Application (2018-2024)
Table 24. Global mRNA Platform Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global mRNA Platform Revenue Market Share by Application (2024-2034)
Table 26. North America mRNA Platform Revenue by Company (2021-2024) & (US$ Million)
Table 27. North America mRNA Platform Revenue by Type (2018-2024) & (US$ Million)
Table 28. North America mRNA Platform Revenue by Type (2024-2034) & (US$ Million)
Table 29. North America mRNA Platform Revenue by Application (2018-2024) & (US$ Million)
Table 30. North America mRNA Platform Revenue by Application (2024-2034) & (US$ Million)
Table 31. North America mRNA Platform Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America mRNA Platform Revenue by Country (2018-2024) & (US$ Million)
Table 33. North America mRNA Platform Revenue by Country (2024-2034) & (US$ Million)
Table 34. Europe mRNA Platform Revenue by Company (2021-2024) & (US$ Million)
Table 35. Europe mRNA Platform Revenue by Type (2018-2024) & (US$ Million)
Table 36. Europe mRNA Platform Revenue by Type (2024-2034) & (US$ Million)
Table 37. Europe mRNA Platform Revenue by Application (2018-2024) & (US$ Million)
Table 38. Europe mRNA Platform Revenue by Application (2024-2034) & (US$ Million)
Table 39. Europe mRNA Platform Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 40. Europe mRNA Platform Revenue by Country (2018-2024) & (US$ Million)
Table 41. Europe mRNA Platform Revenue by Country (2024-2034) & (US$ Million)
Table 42. Asia Pacific mRNA Platform Revenue by Company (2021-2024) & (US$ Million)
Table 43. Asia Pacific mRNA Platform Revenue by Type (2018-2024) & (US$ Million)
Table 44. Asia Pacific mRNA Platform Revenue by Type (2024-2034) & (US$ Million)
Table 45. Asia Pacific mRNA Platform Revenue by Application (2018-2024) & (US$ Million)
Table 46. Asia Pacific mRNA Platform Revenue by Application (2024-2034) & (US$ Million)
Table 47. Asia-Pacific mRNA Platform Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 48. Asia Pacific mRNA Platform Revenue by Region (2018-2024) & (US$ Million)
Table 49. Asia Pacific mRNA Platform Revenue by Region (2024-2034) & (US$ Million)
Table 50. Latin America mRNA Platform Revenue by Company (2021-2024) & (US$ Million)
Table 51. Latin America mRNA Platform Revenue by Type (2018-2024) & (US$ Million)
Table 52. Latin America mRNA Platform Revenue by Type (2024-2034) & (US$ Million)
Table 53. Latin America mRNA Platform Revenue by Application (2018-2024) & (US$ Million)
Table 54. Latin America mRNA Platform Revenue by Application (2024-2034) & (US$ Million)
Table 55. Latin America mRNA Platform Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 56. Latin America mRNA Platform Revenue by Country (2018-2024) & (US$ Million)
Table 57. Latin America mRNA Platform Revenue by Country (2024-2034) & (US$ Million)
Table 58. Middle East and Africa mRNA Platform Revenue by Company (2021-2024) & (US$ Million)
Table 59. Middle East and Africa mRNA Platform Revenue by Type (2018-2024) & (US$ Million)
Table 60. Middle East and Africa mRNA Platform Revenue by Type (2024-2034) & (US$ Million)
Table 61. Middle East and Africa mRNA Platform Revenue by Application (2018-2024) & (US$ Million)
Table 62. Middle East and Africa mRNA Platform Revenue by Application (2024-2034) & (US$ Million)
Table 63. Middle East and Africa mRNA Platform Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Middle East and Africa mRNA Platform Revenue by Country (2018-2024) & (US$ Million)
Table 65. Middle East and Africa mRNA Platform Revenue by Country (2024-2034) & (US$ Million)
Table 66. Arcturus Therapeutic Company Details
Table 67. Arcturus Therapeutic Business Overview
Table 68. Arcturus Therapeutic mRNA Platform Product and Services
Table 69. Arcturus Therapeutic mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 70. Arcturus Therapeutic mRNA Platform SWOT Analysis
Table 71. Arcturus Therapeutic Recent Development
Table 72. Argos Therapeutics Company Details
Table 73. Argos Therapeutics Business Overview
Table 74. Argos Therapeutics mRNA Platform Product and Services
Table 75. Argos Therapeutics mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 76. Argos Therapeutics mRNA Platform SWOT Analysis
Table 77. Argos Therapeutics Recent Development
Table 78. BioNTec Company Details
Table 79. BioNTec Business Overview
Table 80. BioNTec mRNA Platform Product and Services
Table 81. BioNTec mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 82. BioNTec mRNA Platform SWOT Analysis
Table 83. BioNTec Recent Development
Table 84. CureVac Company Details
Table 85. CureVac Business Overview
Table 86. CureVac mRNA Platform Product and Services
Table 87. CureVac mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 88. CureVac mRNA Platform SWOT Analysis
Table 89. CureVac Recent Development
Table 90. Etherna Company Details
Table 91. Etherna Business Overview
Table 92. Etherna mRNA Platform Product and Services
Table 93. Etherna mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 94. Etherna mRNA Platform SWOT Analysis
Table 95. Etherna Recent Development
Table 96. Ethris Company Details
Table 97. Ethris Business Overview
Table 98. Ethris mRNA Platform Product and Services
Table 99. Ethris mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 100. Ethris mRNA Platform SWOT Analysis
Table 101. Ethris Recent Development
Table 102. GlaxoSmithKline Company Details
Table 103. GlaxoSmithKline Business Overview
Table 104. GlaxoSmithKline mRNA Platform Product and Services
Table 105. GlaxoSmithKline mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 106. GlaxoSmithKline mRNA Platform SWOT Analysis
Table 107. GlaxoSmithKline Recent Development
Table 108. Pfizer Company Details
Table 109. Pfizer Business Overview
Table 110. Pfizer mRNA Platform Product and Services
Table 111. Pfizer mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 112. Pfizer mRNA Platform SWOT Analysis
Table 113. Pfizer Recent Development
Table 114. Translate Bio Company Details
Table 115. Translate Bio Business Overview
Table 116. Translate Bio mRNA Platform Product and Services
Table 117. Translate Bio mRNA Platform Revenue in mRNA Platform Business (2018-2024) & (US$ Million)
Table 118. Translate Bio mRNA Platform SWOT Analysis
Table 119. Translate Bio Recent Development
Table 120. mRNA Platform Market Trends
Table 121. mRNA Platform Market Drivers
Table 122. mRNA Platform Market Challenges
Table 123. mRNA Platform Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Platform Product Picture
Figure 2. Global mRNA Platform Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global mRNA Platform Market Share by Type: 2022 VS 2034
Figure 4. Infectious Disease Vaccines Features
Figure 5. Cancer Vaccines Features
Figure 6. Global mRNA Platform Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 7. Global mRNA Platform Market Share by Application: 2022 VS 2034
Figure 8. Infectious Disease
Figure 9. Cancer
Figure 10. mRNA Platform Report Years Considered
Figure 11. Global mRNA Platform Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global mRNA Platform Market Size 2018-2034 (US$ Million)
Figure 13. Global mRNA Platform Market Size Market Share by Region: 2022 VS 2034
Figure 14. Global mRNA Platform Revenue Market Share by Region in 2018 VS 2022
Figure 15. Global mRNA Platform Revenue Market Share Forecast by Region (2024-2034)
Figure 16. Global Top 10 mRNA Platform Countries Ranking by Market Size (US$ Million) in 2022
Figure 17. Global mRNA Platform Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 18. Global mRNA Platform Market Share by Players in 2022
Figure 19. Global Top mRNA Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Platform as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by mRNA Platform Revenue in 2022
Figure 21. North America mRNA Platform Revenue Market Share by Company in 2022
Figure 22. North America mRNA Platform Revenue Market Share by Type (2018-2034)
Figure 23. North America mRNA Platform Revenue Market Share by Application (2018-2034)
Figure 24. North America mRNA Platform Revenue Share by Country (2018-2034)
Figure 25. United States mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 26. Canada mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 27. Europe mRNA Platform Revenue Market Share by Company in 2022
Figure 28. Europe mRNA Platform Revenue Market Share by Type (2018-2034)
Figure 29. Europe mRNA Platform Revenue Market Share by Application (2018-2034)
Figure 30. Europe mRNA Platform Revenue Share by Country (2018-2034)
Figure 31. Germany mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 32. France mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 33. U.K. mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 34. Italy mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 35. Russia mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 36. Asia Pacific mRNA Platform Revenue Market Share by Company in 2022
Figure 37. Asia Pacific mRNA Platform Revenue Market Share by Type (2018-2034)
Figure 38. Asia Pacific mRNA Platform Revenue Market Share by Application (2018-2034)
Figure 39. Asia Pacific mRNA Platform Revenue Share by Region (2018-2034)
Figure 40. China mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 41. Japan mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 42. South Korea mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 43. India mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 44. Australia mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 45. China Taiwan mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 46. Indonesia mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 47. Thailand mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 48. Malaysia mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 49. Latin America mRNA Platform Revenue Market Share by Company in 2022
Figure 50. Latin America mRNA Platform Revenue Market Share by Type (2018-2034)
Figure 51. Latin America mRNA Platform Revenue Market Share by Application (2018-2034)
Figure 52. Latin America mRNA Platform Revenue Share by Country (2018-2034)
Figure 53. Mexico mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 54. Brazil mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 55. Argentina mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 56. Middle East and Africa mRNA Platform Revenue Market Share by Company in 2022
Figure 57. Middle East and Africa mRNA Platform Revenue Market Share by Type (2018-2034)
Figure 58. Middle East and Africa mRNA Platform Revenue Market Share by Application (2018-2034)
Figure 59. Middle East and Africa mRNA Platform Revenue Share by Country (2018-2034)
Figure 60. Turkey mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 61. Saudi Arabia mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 62. UAE mRNA Platform Revenue (2018-2034) & (US$ Million)
Figure 63. Arcturus Therapeutic Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 64. Argos Therapeutics Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 65. BioNTec Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 66. CureVac Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 67. Etherna Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 68. Ethris Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 69. GlaxoSmithKline Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 70. Pfizer Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 71. Translate Bio Revenue Growth Rate in mRNA Platform Business (2018-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed